BLK vs LLY: Which Is the Better Buy?
Side-by-side comparison of BlackRock, Inc. and Eli Lilly and Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-22.
BlackRock, Inc. · Financial Services
$1,042.85
+125.5% upside to fair value
Grade A
High Quality
VS
Eli Lilly and Company · Healthcare
$939.47
+71.1% upside to fair value
High Conviction
Grade A
QuantHub Verdict
BLK has more upside to fair value
(+125.5%).
BLK trades at a lower forward P/E
(25.9x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
BLK |
LLY |
| Current Price |
$1,042.85 |
$939.47 |
| Fair Value Estimate |
$2,351.12 |
$1,607.00 |
| Upside to Fair Value |
+125.5%
|
+71.1%
|
| Market Cap |
$162.2B |
$887.6B |
| Forward P/E |
25.9x
|
27.4x
|
| EV / EBITDA |
16.9x
|
35.8x
|
| Price / Sales |
6.3x
|
14.8x
|
| Price / FCF |
45.2x
|
107.6x
|
| Revenue Growth YoY |
+28.3%
|
+44.7%
|
| Gross Margin |
59.1%
|
83.8%
|
| Operating Margin |
29.9%
|
45.6%
|
| Return on Equity |
12.0%
|
77.8%
|
| Dividend Yield |
0% |
0.56% |
| FCF Yield |
2.21%
|
0.93%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
BlackRock, Inc. is the world's largest asset manager with over $14 trillion in assets under management, operating primarily in financial services and asset management. The company benefits from a durable competitive moat driven by its scale, technology platform Aladdin, and founder-led management with CEO Laurence D. Fink at the helm since inception. BlackRock exhibits strong fundamentals includi…
Eli Lilly remains the dominant GLP-1 franchise holder with Mounjaro and Zepbound generating $36.5B combined in 2025 on 45% total revenue growth to $65.2B. The company guided $80-83B for 2026, well above prior Street consensus, and launched Foundayo (oral GLP-1, FDA approved April 2026) with $1.5B pre-built inventory. At $939 the stock trades at 14.8x P/S, right at its 5-year median, and 27.4x for…
Accumulation Zones
| Metric |
BLK |
LLY |
| Zone Low |
$1,763.34 |
$1,205.00 |
| Zone High |
$1,998.45 |
$1,366.00 |
| In Buy Zone? |
Yes
|
Yes
|